ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 01 Apr 2023
Last Applicant/ Owned by
One Kendall Sq.
Cambridge
MA
02139
Serial Number
97220299 filed on 14th Jan 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DIAMOND
Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of drug discovery and healthcare Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders
Class [042]
Computer & Software Services & Scientific Services
Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; scientific research, namely, research and analysis services featuring artificial intelligence and machine learning analytics in the fields of healthcare, biomedical and genomic research; research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; research and development of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials
Mark Details
Serial Number
No 97220299
Mark Type
No Service Mark
Attorney Docket Number
No F08472000300
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Apr 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 01st Apr 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 01st Apr 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 14th Sep 2022 | NON-FINAL ACTION E-MAILED |
| 14th Sep 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 14th Sep 2022 | NON-FINAL ACTION WRITTEN |
| 18th Aug 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 17th Aug 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 17th Aug 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th Jul 2022 | NON-FINAL ACTION E-MAILED |